AAAAAA
Results:
1-8
|
Results: 8
Authors:
Nahde, T
Muller, K
Fahr, A
Muller, R
Brusselbach, S
Citation: T. Nahde et al., Combined transductional and transcriptional targeting of melanoma cells byartificial virus-like particles, J GENE MED, 3(4), 2001, pp. 353-361
Authors:
Heine, D
Muller, R
Brusselbach, S
Citation: D. Heine et al., Cell surface display of a lysosomal enzyme for extracellular gene-directedenzyme prodrug therapy, GENE THER, 8(13), 2001, pp. 1005-1010
Authors:
Muller, K
Nahde, T
Fahr, A
Muller, R
Brusselbach, S
Citation: K. Muller et al., Highly efficient transduction of endothelial cells by targeted artificial virus-like particles, CANC GENE T, 8(2), 2001, pp. 107-117
Authors:
Fischer, D
Bieber, T
Brusselbach, S
Elsasser, HP
Kissel, T
Citation: D. Fischer et al., Cationized human serum albumin as a non-viral vector system for gene delivery? Characterization of complex formation with plasmid DNA and transfection efficiency, INT J PHARM, 225(1-2), 2001, pp. 97-111
Authors:
Weyel, D
Sedlacek, HH
Muller, R
Brusselbach, S
Citation: D. Weyel et al., Secreted human beta-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy, GENE THER, 7(3), 2000, pp. 224-231
Authors:
Brusselbach, S
Korn, T
Volkel, T
Muller, R
Kontermann, RE
Citation: S. Brusselbach et al., Enzyme recruitment and tumor cell killing in vitro by a secreted bispecific single-chain diabody, TUMOR TARG, 4(2), 1999, pp. 115-123
Authors:
Zwicker, J
Brusselbach, S
Jooss, KU
Sewing, A
Behn, M
Lucibello, FC
Muller, R
Citation: J. Zwicker et al., Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation, ONCOGENE, 18(1), 1999, pp. 19-25
Authors:
Pizzimenti, S
Barrera, G
Dianzani, MU
Brusselbach, S
Citation: S. Pizzimenti et al., Inhibition of D1, D2, and a cyclin expression in HL-60 cells by the lipid peroxydation product 4-hydroxynonenal, FREE RAD B, 26(11-12), 1999, pp. 1578-1586
Risultati:
1-8
|